Meanwhile, children aged 6-11 years with a current ASD diagnosis were almost 4 times more likely to have had a past speech problem and 3.5 times more likely to have current moderate or severe anxiety than were children with a PBNC diagnosis.
Finally, adolescents aged 12-17 years with a current ASD diagnosis were almost 4 times more likely to have moderate or severe speech problems and 10 times more likely to have current mild seizures or epilepsy than children with a PBNC diagnosis of ASD.
Children and adolescents with a current ASD diagnosis were more likely to have two or more co-occurring conditions than those with a PBNC diagnosis.
In this study, the researchers focused on the possible impact that neurodevelopmental and psychiatric conditions could have on the continuation of ASD diagnosis by comparing groups who currently have an ASD diagnosis to groups with a PBNC diagnosis.
PBNCs to diagnose a variety of diseases are currently the focus of six human clinical trials.
PBNCs capture biomarkers - molecules that offer information about a person's health -found in blood, saliva and other bodily fluids.
This included specific criteria for safe, therapeutic transfer techniques specific to frail elderly residents and reflected the standards taught in the PBNC transfer class.
* 93% reported doing two-person transfers with one in front and one in back, as instructed in PBNC transfer classes.
This was addressed with an in-service by PBNC's Mental Health Nurse.
Transfer training classes have expanded to include employees at all levels of care in the PBNC system, including the home health agency, assisted living center and adult foster homes.